Replies to post #82 on AngioGenex, Inc. (fka AGGX)

[db7]

I'll see if anyone can provide examples. I am in no means claiming to be an expert in this...

If I'm reading their filing correctly, I do notice that they are 'possibly' a disruptor in a least one $billion market.. possibly more.

and then this:
"
Since their discovery more than twenty years ago, Dr. Robert Benezra, the Company Chief Scientific and Executive Officer and a Member at Memorial Sloan Kettering Cancer Center (“MSKCC”)
"


Time will tell.. but if ever one were to come back I think this one has a good chance.

g/l!